13.12

2.86% 0.365

After Hours: 13.14 0.025 +0.19%

Avadel Pharmaceuticals Plc (AVDL)

Overview News Price History Option Chain Financials Why AVDL Down? Discussions Forecast

Avadel Pharmaceuticals Plc stock is traded at $13.12, with a volume of 1.72M. It is up +2.86% in the last 24 hours and down -13.55% over the past month. Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Previous Close:

$12.75

Open:

$12.71

24h Volume:

1.72M

Relative Volume:

1.44

Market Cap:

$1.24B

Revenue:

$47.56M

Net Income/Loss:

$-156.83M

P/E Ratio:

-6.3053

EPS:

-2.08

Net Cash Flow:

$-127.98M

1W Performance:

+1.90%

1M Performance:

-13.55%

6M Performance:

-22.35%

1Y Performance:

+27.33%

1-Day Range:

$12.57

$13.41

1-Week Range:

$12.56

$13.41

52-Week Range:

$9.50

$19.09

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Name

Avadel Pharmaceuticals Plc

Sector

Healthcare (1190)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

636-449-1830

Address

BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN

Employee

154

Twitter

@AvadelPharma

Next Earnings Date

2024-08-08

Latest SEC Filings

AVDL's Discussions on Twitter

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-06-24	Initiated	UBS	Buy
Nov-30-22	Upgrade	Jefferies	Hold → Buy
Aug-10-22	Downgrade	Jefferies	Buy → Hold
Jul-28-22	Resumed	Craig Hallum	Buy
May-26-22	Downgrade	Stifel	Buy → Hold
Sep-23-21	Initiated	Needham	Buy
Jul-31-20	Initiated	Oppenheimer	Outperform
Jul-21-20	Initiated	SVB Leerink	Outperform
Jun-30-20	Initiated	H.C. Wainwright	Buy
Apr-03-20	Initiated	Jefferies	Buy
Mar-12-20	Initiated	Stifel	Buy
Feb-26-20	Initiated	Piper Sandler	Overweight
Jan-30-20	Initiated	Craig Hallum	Buy
Jun-14-19	Upgrade	Ladenburg Thalmann	Neutral → Buy
Feb-08-19	Downgrade	Ladenburg Thalmann	Buy → Neutral

View All

Avadel Pharmaceuticals Plc Stock (AVDL) Latest News

Sep 27, 2024

How does Avadel Pharmaceuticals plc (AVDL) change from a tortoise to a hare? - SETE News

Sep 27, 2024

Sep 25, 2024

A stock that deserves closer examination: Avadel Pharmaceuticals plc (AVDL) - US Post News

Sep 25, 2024

AVDLAvadel Pharmaceuticals plc Ordinary Share Latest Stock News & Market Updates - StockTitan

Sep 25, 2024

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent - StockTitan

Sep 25, 2024

Troluce Capital Advisors LLC Invests $2.11 Million in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat

Sep 25, 2024

Sep 24, 2024

Trading Day Triumph: Avadel Pharmaceuticals plc (AVDL) Ends at 12.87, a -3.96 Surge/Plunge - The Dwinnex

Sep 24, 2024

Sep 23, 2024

Ally Bridge Group NY LLC Decreases Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat

Sep 23, 2024

Ally Bridge Group NY LLC Sells 116,791 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Sep 23, 2024

Sep 22, 2024

Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (update) - MSN

Sep 22, 2024

Sep 21, 2024

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by Rhumbline Advisers - MarketBeat

Sep 21, 2024

Sep 18, 2024